Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Curriculum heart failure : Task force curriculum heart failure of the working group on heart failure of the Austrian Cardiological Society.

Berger R, Hülsmann M, Mörtl D, Pölzl G.

Wien Klin Wochenschr. 2019 Jul;131(13-14):299-312. doi: 10.1007/s00508-019-1480-y. Epub 2019 May 30.

2.

Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry.

Odeneg T, Ebner C, Mörtl D, Keller H, Dirninger A, Stix G, Föger B, Grimm G, Steinwender C, Gebetsberger F, Stühlinger M, Mastnak B, Haider C, Manninger M, Scherr D.

Eur J Cardiovasc Nurs. 2019 Jan;18(1):75-83. doi: 10.1177/1474515118790365. Epub 2018 Aug 1.

PMID:
30064269
3.

Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.

Sponder M, Khazen C, Dichtl W, Fiedler L, Mörtl D, Teubl A, Steinwender C, Martinek M, Nürnberg M, Dalos D, Kastner J, Schukro C.

Eur J Intern Med. 2018 Feb;48:64-68. doi: 10.1016/j.ejim.2017.09.038. Epub 2017 Oct 1.

PMID:
28978409
4.

Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure.

Koller L, Richter B, Winter MP, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Lang I, Wojta J, Hülsmann M, Niessner A.

J Clin Lipidol. 2017 Jan - Feb;11(1):178-184. doi: 10.1016/j.jacl.2016.11.009. Epub 2016 Dec 7.

PMID:
28391884
5.

Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.

Koller L, Stojkovic S, Richter B, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Wojta J, Hülsmann M, Niessner A.

JACC Heart Fail. 2017 Apr;5(4):268-277. doi: 10.1016/j.jchf.2016.12.008.

6.

Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients With Heart Failure and Reduced Ejection Fraction.

Koller L, Kleber ME, Brandenburg VM, Goliasch G, Richter B, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer TB, Delgado G, Tomaschitz A, Pilz S, Berger R, Mörtl D, Hülsmann M, Pacher R, März W, Niessner A.

Circ Heart Fail. 2015 Nov;8(6):1059-67. doi: 10.1161/CIRCHEARTFAILURE.115.002341. Epub 2015 Aug 13.

PMID:
26273098
7.

A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure.

Richter B, Koller L, Hohensinner PJ, Zorn G, Brekalo M, Berger R, Mörtl D, Maurer G, Pacher R, Huber K, Wojta J, Hülsmann M, Niessner A.

Int J Cardiol. 2013 Sep 30;168(2):1251-7. doi: 10.1016/j.ijcard.2012.11.052. Epub 2012 Dec 4.

PMID:
23218577
8.

Fractalkine is an independent predictor of mortality in patients with advanced heart failure.

Richter B, Koller L, Hohensinner PJ, Rychli K, Zorn G, Goliasch G, Berger R, Mörtl D, Maurer G, Huber K, Pacher R, Wojta J, Hülsmann M, Niessner A.

Thromb Haemost. 2012 Dec;108(6):1220-7. doi: 10.1160/TH12-03-0195. Epub 2012 Sep 26.

PMID:
23014777
9.

Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure.

Rychli K, Richter B, Hohensinner PJ, Kariem Mahdy A, Neuhold S, Zorn G, Berger R, Mörtl D, Huber K, Pacher R, Wojta J, Niessner A, Hülsmann M.

Heart. 2011 Jul;97(14):1158-63. doi: 10.1136/hrt.2010.220228. Epub 2011 May 14.

PMID:
21572126
10.

Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure.

Richter B, Rychli K, Hohensinner PJ, Berger R, Mörtl D, Neuhold S, Zorn G, Huber K, Maurer G, Wojta J, Pacher R, Hülsmann M, Niessner A.

Atherosclerosis. 2010 Dec;213(2):545-8. doi: 10.1016/j.atherosclerosis.2010.08.061. Epub 2010 Aug 19.

PMID:
20843516
11.

Prognostic value of pigment epithelium-derived factor in patients with advanced heart failure.

Rychli K, Niessner A, Hohensinner PJ, Mahdy Ali K, Kaun C, Neuhold S, Zorn G, Richter B, Hülsmann M, Berger R, Mörtl D, Huber K, Maurer G, Pacher R, Wojta J.

Chest. 2010 Sep;138(3):656-64. doi: 10.1378/chest.09-2739. Epub 2010 Apr 30.

PMID:
20435653
12.

Macrophage-modulating cytokines predict adverse outcome in heart failure.

Hohensinner PJ, Rychli K, Zorn G, Hülsmann M, Berger R, Mörtl D, Richter B, Huber K, Wojta J, Pacher R, Niessner A.

Thromb Haemost. 2010 Feb;103(2):435-41. doi: 10.1160/TH09-06-0399. Epub 2010 Jan 13.

PMID:
20076846
13.

Prognostic value of apoptosis markers in advanced heart failure patients.

Niessner A, Hohensinner PJ, Rychli K, Neuhold S, Zorn G, Richter B, Hülsmann M, Berger R, Mörtl D, Huber K, Wojta J, Pacher R.

Eur Heart J. 2009 Apr;30(7):789-96. doi: 10.1093/eurheartj/ehp004. Epub 2009 Feb 4.

PMID:
19196721
14.

Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.

Adlbrecht C, Hülsmann M, Strunk G, Berger R, Mörtl D, Struck J, Morgenthaler NG, Bergmann A, Jakowitsch J, Maurer G, Lang IM, Pacher R.

Eur J Heart Fail. 2009 Apr;11(4):361-6. doi: 10.1093/eurjhf/hfp004. Epub 2009 Feb 3.

15.

Interactions of glucose metabolism and chronic heart failure.

Clodi M, Resl M, Stelzeneder D, Pacini G, Tura A, Mörtl D, Struck J, Morgenthaler NG, Bergmann A, Riedl M, Anderwald-Stadler M, Luger A, Pacher R, Hülsmann M.

Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):99-106. doi: 10.1055/s-2008-1081211. Epub 2008 Sep 30.

PMID:
19085703
16.

Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.

Adlbrecht C, Kommata S, Hülsmann M, Szekeres T, Bieglmayer C, Strunk G, Karanikas G, Berger R, Mörtl D, Kletter K, Maurer G, Lang IM, Pacher R.

Eur Heart J. 2008 Oct;29(19):2343-50. doi: 10.1093/eurheartj/ehn359. Epub 2008 Aug 12.

PMID:
18701467
17.

Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.

Stoiser B, Mörtl D, Hülsmann M, Berger R, Struck J, Morgenthaler NG, Bergmann A, Pacher R.

Eur J Clin Invest. 2006 Nov;36(11):771-8.

PMID:
17032344
18.

Flow-mediated vasodilation predicts outcome in patients with chronic heart failure: comparison with B-type natriuretic peptide.

Meyer B, Mörtl D, Strecker K, Hülsmann M, Kulemann V, Neunteufl T, Pacher R, Berger R.

J Am Coll Cardiol. 2005 Sep 20;46(6):1011-8.

21.

Muscle strength as a predictor of long-term survival in severe congestive heart failure.

Hülsmann M, Quittan M, Berger R, Crevenna R, Springer C, Nuhr M, Mörtl D, Moser P, Pacher R.

Eur J Heart Fail. 2004 Jan;6(1):101-7.

22.

Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization.

Mörtl D, Agneter E, Krivanek P, Koppatz K, Todt H.

J Cardiovasc Pharmacol. 2003 Jun;41(6):870-9.

PMID:
12775964
23.

Comparison of transesophageal Doppler coronary flow reserve measurements with thallium-201 single-photon emission computed tomography imaging in assessment of left anterior descending artery stenoses.

Zehetgruber M, Mörtl D, Porenta G, Mundigler G, Christ G, Lengauer R, Stix G, Probst P, Maurer G, Sochor H, Siostrzonek P.

Clin Cardiol. 1998 Apr;21(4):247-52.

24.

Transesophageal versus intracoronary Doppler measurements for calculation of coronary flow reserve.

Zehetgruber M, Porenta G, Mundigler G, Mörtl D, Binder T, Christ G, Probst P, Baumgartner H, Maurer G, Siostrzonek P.

Cardiovasc Res. 1997 Oct;36(1):21-7.

PMID:
9415268
25.

Estimation of coronary flow reserve by transesophageal coronary sinus Doppler measurements in patients with syndrome X and patients with significant left coronary artery disease.

Zehetgruber M, Mundigler G, Christ G, Mörtl D, Probst P, Baumgartner H, Maurer G, Siostrzonek P.

J Am Coll Cardiol. 1995 Apr;25(5):1039-45.

26.

[Change in the patient profile in coronary heart disease at the time of initial evaluation with coronary angiography between 1975 and 1989].

Gottsauner-Wolf M, Gwechenberger M, Mörtl D, Sochor H, Stockenhuber F, Probst P.

Z Kardiol. 1995 Feb;84(2):81-5. German.

PMID:
7717021

Supplemental Content

Support Center